LPDX Key Stats
|Revenue (Quarterly YoY Growth)||Upgrade|
|EPS Diluted (TTM)||-0.8833|
|EPS Diluted (Quarterly YoY Growth)||Upgrade|
|Net Income (TTM)||-13.34M|
|Gross Profit Margin (Quarterly)||72.79%|
|Profit Margin (Quarterly)||-44.84%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM)||Upgrade|
PR Newswire06/24 08:00
PR Newswire06/14 13:00
LPDX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). LipoScience is down 35.74% over the last year vs S&P 500 Total Return up 20.37%, BG Medicine down 35.74%, and Rosetta Genomics up 34.04%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for LPDX
Portfolio Strategies Featuring LPDX
Did LipoScience make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Diagnostics & Research
- Company Website: http://www.liposcience.com
- IR Website: http://investor.liposcience.com/
- HQ Country: United States
- HQ State/Province: North Carolina
- Incorporation Country: United States
- Incorporation State/Province: Delaware
- Est. Current Fiscal Quarter End: September 30, 2014
- Est. Current Fiscal Year End: December 31, 2014
- Last Fiscal Quarter End: June 30, 2014
- Last Fiscal Year End: December 31, 2013
- NAICS: In-Vitro Diagnostic Substance Manufacturing
- NAICS Code: 325413
- NAICS Industry: Pharmaceutical and Medicine Manufacturing
- NAICS Sector: Manufacturing
LipoScience Inc is a clinical diagnostic company. The Company focuses on new field of personalized diagnostics based on nuclear magnetic resonance or NMR technology.
LPDX Excel Add-In Codes
- Name: =YCI("LPDX","name")
- Description: =YCI("LPDX","description")
- Sector: =YCI("LPDX","sector")
- Industry: =YCI("LPDX","industry")
- Est. Current Fiscal Year End: =YCI("LPDX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.